Completed OBSERVATIONAL NCT02299739

Liver Enzyme Abnormalities and Risk Factors in Taking Herbal Medicine

Liver Enzyme Abnormalities and Its Risk Factors in Taking Traditional Herbal Medicine in Korea

Sponsor: Jaseng Hospital of Korean Medicine

Conditions Drug-Induced Liver Injury Musculoskeletal Diseases

Interventions Acupuncture Bee venom pharmacopuncture Chuna manipulation Herbal medicine Pharmacopuncture

Updated 8 times since 2017 Last updated: Nov 5, 2018 Started: Dec 31, 2005 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02299739, this observational or N/A phase trial focuses on Drug-Induced Liver Injury and Musculoskeletal Diseases and remains completed. Sponsored by Jaseng Hospital of Korean Medicine, it has been updated 8 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Dec 2018 — Jan 2021 [monthly]

Completed

▶ Show 3 earlier versions

Jun 2018 — Dec 2018 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Dec 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jaseng Hospital of Korean Medicine

Data source: Jaseng Hospital of Korean Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea